List of Raptor Pharmaceuticals patents

List of Raptor Pharmaceuticals patents

List of University of Medicine and Dentistry of New Jersey patents

List of Laerdal Medical (company) patents

List of Webtrends patents

List of SBIR/STTR awards granted to NAVISCAN PET SYSTEMS, INC.

List of AI water industry companies

Patents where

Current Assignee

Name

is

Raptor Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7829537 Receptor associated protein (RAP) conjugates	Patent 7829537 was granted and assigned to Raptor Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.		Raptor Pharmaceuticals		United States Patent and Trademark Office	7829537	November 9, 2010
	‌ US Patent 7700554 Compositions for modulating blood-brain barrier transport	Patent 7700554 was granted and assigned to Raptor Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		Raptor Pharmaceuticals		United States Patent and Trademark Office	7700554	April 20, 2010
	‌ US Patent 9326971 4-methylpyrazole formulations for inhibiting ethanol intolerance	Patent 9326971 was granted and assigned to Raptor Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.	Raptor Pharmaceuticals	Raptor Pharmaceuticals		United States Patent and Trademark Office	9326971	May 3, 2016
	‌ US Patent 9233077 Delayed release cysteamine bead formulation, and methods of making and using same	Patent 9233077 was granted and assigned to Raptor Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office.	Raptor Pharmaceuticals	Raptor Pharmaceuticals		United States Patent and Trademark Office	9233077	January 12, 2016
	‌ US Patent 9435785 Methods for analyzing cysteamine compositions	Patent 9435785 was granted and assigned to Raptor Pharmaceuticals on September, 2016 by the United States Patent and Trademark Office.	Raptor Pharmaceuticals	Raptor Pharmaceuticals		United States Patent and Trademark Office	9435785	September 6, 2016
	‌ US Patent 9062126 Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof	Patent 9062126 was granted and assigned to Raptor Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.		Raptor Pharmaceuticals		United States Patent and Trademark Office	9062126	June 23, 2015
	‌ US Patent 9326936 Aerosol fluoroquinolone formulations for improved pharmacokinetics	Patent 9326936 was granted and assigned to Raptor Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.	Raptor Pharmaceuticals	Raptor Pharmaceuticals		United States Patent and Trademark Office	9326936	May 3, 2016
	‌ US Patent 8440629 Cyclic receptor-associated protein (RAP) peptides	Patent 8440629 was granted and assigned to Raptor Pharmaceuticals on May, 2013 by the United States Patent and Trademark Office.		Raptor Pharmaceuticals		United States Patent and Trademark Office	8440629	May 14, 2013
	‌ US Patent 9173851 Delayed release cysteamine bead formulation, and methods of making and using same	Patent 9173851 was granted and assigned to Raptor Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.	Raptor Pharmaceuticals	Raptor Pharmaceuticals		United States Patent and Trademark Office	9173851	November 3, 2015
	‌ US Patent 9173850 4-methylpyrazole formulations	Patent 9173850 was granted and assigned to Raptor Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.		Raptor Pharmaceuticals		United States Patent and Trademark Office	9173850	November 3, 2015
	‌ US Patent 8609103 Megalin-based delivery of therapeutic compounds to the brain and other tissues	Patent 8609103 was granted and assigned to Raptor Pharmaceuticals on December, 2013 by the United States Patent and Trademark Office.		Raptor Pharmaceuticals		United States Patent and Trademark Office	8609103	December 17, 2013
	‌ US Patent 8795627 Treatment of liver disorders by administration of RAP conjugates	Patent 8795627 was granted and assigned to Raptor Pharmaceuticals on August, 2014 by the United States Patent and Trademark Office.		Raptor Pharmaceuticals		United States Patent and Trademark Office	8795627	August 5, 2014

12 results

0 selected

12 results

0 selected